Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with a transaction set to propel the company into the CDMO market.

BYD contractor Jinjiang imposed restrictive labor conditions on Chinese workers BYD denies knowledge of labor violations, claims unawareness until media reports BYD and Jinjiang face charges for ...

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to announce this acquisition. With our shared commitment to creating the best ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances ...

In a report released today, Alex NG from CMB International Securities reiterated a Buy rating on BYD Electronic (International) Co (BYDIF – ...

BYD is widely considered the new kid on the block, but they're making a big splash in foreign markets where domestic automakers typically dominate. Per Electrek, BYD moved in on Toyota’s turf ...